- Home
- DSS vs FOXO Comparison
DSS vs FOXO Comparison
Compare DSS & FOXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSS
- FOXO
- Stock Information
- Founded
- DSS 1984
- FOXO 2019
- Country
- DSS United States
- FOXO United States
- Employees
- DSS N/A
- FOXO N/A
- Industry
- DSS Containers/Packaging
- FOXO Retail: Computer Software & Peripheral Equipment
- Sector
- DSS Consumer Discretionary
- FOXO Technology
- Exchange
- DSS Nasdaq
- FOXO Nasdaq
- Market Cap
- DSS 7.3M
- FOXO 4.9M
- IPO Year
- DSS N/A
- FOXO N/A
- Fundamental
- Price
- DSS $0.84
- FOXO $0.15
- Analyst Decision
- DSS
- FOXO
- Analyst Count
- DSS 0
- FOXO 0
- Target Price
- DSS N/A
- FOXO N/A
- AVG Volume (30 Days)
- DSS 11.7K
- FOXO 5.9M
- Earning Date
- DSS 03-26-2025
- FOXO 11-19-2024
- Dividend Yield
- DSS N/A
- FOXO N/A
- EPS Growth
- DSS N/A
- FOXO N/A
- EPS
- DSS N/A
- FOXO N/A
- Revenue
- DSS $25,019,000.00
- FOXO $1,341,000.00
- Revenue This Year
- DSS N/A
- FOXO N/A
- Revenue Next Year
- DSS N/A
- FOXO N/A
- P/E Ratio
- DSS N/A
- FOXO N/A
- Revenue Growth
- DSS N/A
- FOXO 196.03
- 52 Week Low
- DSS $0.77
- FOXO $0.13
- 52 Week High
- DSS $2.30
- FOXO $1.30
- Technical
- Relative Strength Index (RSI)
- DSS 41.07
- FOXO 36.77
- Support Level
- DSS $0.85
- FOXO $0.14
- Resistance Level
- DSS $0.93
- FOXO $0.17
- Average True Range (ATR)
- DSS 0.04
- FOXO 0.02
- MACD
- DSS -0.01
- FOXO 0.00
- Stochastic Oscillator
- DSS 0.00
- FOXO 8.00
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.
About FOXO FOXO Technologies Inc.
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.